Impact of Attention-Deficit/Hyperactivity Disorder (ADHD) on prescription dug spending for children and adolescents: increasing relevance of health economic evidence

BACKGROUND: During the last decade, pharmaceutical spending for patients with attention-deficit-hyperactivity disorder (ADHD) has been escalating internationally. OBJECTIVES: First, to estimate future trends of ADHD-related drug expenditures from the perspectives of the statutory health insurance (S...

Descripción completa

Detalles Bibliográficos
Autor principal: Schlander, Michael
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2216002/
https://www.ncbi.nlm.nih.gov/pubmed/18005403
http://dx.doi.org/10.1186/1753-2000-1-13

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2216002/
https://www.ncbi.nlm.nih.gov/pubmed/18005403
http://dx.doi.org/10.1186/1753-2000-1-13

Ejemplares similares